KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Income from Non-Controlling Interests: 2009-2020

Historic Income from Non-Controlling Interests for Ionis Pharmaceuticals (IONS) over the last 4 years, with Dec 2020 value amounting to -$1.2 million.

  • Ionis Pharmaceuticals' Income from Non-Controlling Interests fell 105.91% to -$1.2 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$35.5 million, marking a year-over-year decrease of 489.21%. This contributed to the annual value of -$35.5 million for FY2020, which is 489.21% down from last year.
  • According to the latest figures from Q4 2020, Ionis Pharmaceuticals' Income from Non-Controlling Interests is -$1.2 million, which was up 90.49% from -$12.1 million recorded in Q3 2020.
  • Ionis Pharmaceuticals' Income from Non-Controlling Interests' 5-year high stood at $19.5 million during Q4 2019, with a 5-year trough of -$17.3 million in Q4 2018.
  • In the last 3 years, Ionis Pharmaceuticals' Income from Non-Controlling Interests had a median value of -$9.8 million in 2018 and averaged -$7.1 million.
  • As far as peak fluctuations go, Ionis Pharmaceuticals' Income from Non-Controlling Interests skyrocketed by 212.67% in 2019, and later plummeted by 259.20% in 2020.
  • Ionis Pharmaceuticals' Income from Non-Controlling Interests (Quarterly) stood at -$6.2 million in 2017, then crashed by 177.64% to -$17.3 million in 2018, then skyrocketed by 212.67% to $19.5 million in 2019, then crashed by 105.91% to -$1.2 million in 2020.
  • Its last three reported values are -$1.2 million in Q4 2020, -$12.1 million for Q3 2020, and -$11.9 million during Q2 2020.